2,303 results on '"Ohyama, Chikara"'
Search Results
2. Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study
3. Association between oral frailty and lower urinary tract symptoms among middle-aged and older adults in community-dwelling individuals: a cross-sectional study
4. ASO Visual Abstract: Long-Term Outcomes of Orthotopic Neobladder versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium
5. Comparison of outcomes in kidney transplantations involving blood-related and non-blood-related living donors: a multicenter retrospective study by the Michinoku renal transplant network
6. Association between sex hormones and erectile dysfunction in men without hypoandrogenism
7. Impact of severe acute kidney injury on short-term mortality in urosepsis
8. TMEM2 suppresses TLR3-mediated IFN-β/ISG56/CXCL10 expression in BEAS-2B bronchial epithelial cells
9. Impact of timing of rejection episode on cardiovascular events in living donor kidney transplantation: a multicenter retrospective study
10. Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group
11. Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old
12. Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study
13. Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis
14. Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
15. Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
16. A retrospective study on the incidence, management and risk factors of skin rash in patients with advanced prostate cancer in Japan
17. Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial
18. Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study
19. Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study
20. Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel
21. TMEM2 Is a Bona Fide Hyaluronidase Possessing Intrinsic Catalytic Activity
22. MP14-05 THE IMPACT OF UPFRONT COMBINATION THERAPY IN PATIENTS WITH MCSPC ON OS AFTER MCRPC: A MULTICENTRE RETROSPECTIVE STUDY
23. MP75-02 CAUSAL RELATIONSHIP BETWEEN LOWER URINARY TRACT SYMPTOMS AND FRAILTY: THE CHICKEN OR THE EGG DILEMMA
24. MP69-09 ROLE OF SERUM IMMUNOGLOBULIN N-GLYCANS IN THE PROTECTION OF ENDOTHELIAL GLYCOCALYX IN UROLOGICAL SEPSIS
25. MP16-10 SAFETY AND EFFICACY OF INTENSIVE INSTILLATION OF LOW-DOSE PIRARUBICIN VS. BACILLUS CALMETTE-GUÉRIN IN HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
26. PD38-06 EFFECT OF MAXIMAL TRANSURETHRAL RESECTION PRIOR TO NEOADJUVANT CHEMOTHERAPY ON ONCOLOGICAL OUTCOMES IN PATIENTS WHO UNDERGO RADICAL CYSTECTOMY: A MULTICENTER RETROSPECTIVE STUDY
27. MP66-18 ASSOCIATION BETWEEN AORTIC CALCIFICATION BURDEN AND ERECTILE DYSFUNCTION SEVERITY IN MEN UNDERGOING DIALYSIS: A CROSS-SECTIONAL STUDY
28. MP74-02 CHARACTERISTICS OF THE α2,3-SIALYL N-GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN AS A BIOMARKER FOR PROSTATE CANCER IN MEN WITH GREY ZONE LEVELS OF THE PROSTATE-SPECIFIC ANTIGEN
29. MP14-14 THE IMPACT OF DELAYED ADMINISTRATION OF ANDROGEN-RECEPTOR SIGNALING INHIBITORS (ARSI) ON PROGNOSIS FOR MHNPC
30. PD43-08 SERUM SEROTONIN LEVELS AS a POTENTIAL RISK FACTOR FOR OVERACTIVE BLADDER IN A COMMUNITY-DWELLING POPULATION: A 4-YEAR LONGITUDINAL STUDY
31. MP22-03 THE EFFECT OF LYMPHOVASCULAR INVASION ON ONCOLOGICAL OUTCOMES BETWEEN pT2 AND ypT2 IN PATIENTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA
32. MP22-04 EFFECTS OF RADIATION THERAPY TO THE RECURRENCE SITES ON ONCOLOGICAL OUTCOMES IN PATIENTS WHO EXPERIENCED LOCAL RECURRENCE AND/OR PELVIC LYMPH NODE METASTASES AFTER RADICAL CYSTECTOMY: A MULTICENTER RETROSPECTIVE STUDY
33. Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data
34. Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy
35. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
36. Kidney Transplantation in a Patient With Noonan Syndrome: A Case Report
37. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer
38. Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
39. Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study
40. Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
41. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients
42. Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
43. Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy.
44. Associations of remaining teeth number, periodontal disease, and occlusal support status with erectile dysfunction in community‐dwelling men.
45. The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan
46. Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
47. Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer
48. Altered gut microbiome associated with overactive bladder and daily urinary urgency
49. Glycan Biomarkers for Cancer and Various Disease
50. Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.